Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas

Biobadaser Fase III

Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry. Rheumatology international. 2019;39(3):509-15.

28/02/2022

Hernandez MV, Sanchez-Piedra C, Garcia-Magallon B, Cuende E, Manero J, Campos-Fernandez C, et al

Epub 2018/10/26. doi: 10.1007/s00296-018-4177-z. PubMed PMID: 30353269.